These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28108325)

  • 1. Mononuclear phagocytes as a target, not a barrier, for drug delivery.
    Yong SB; Song Y; Kim HJ; Ain QU; Kim YH
    J Control Release; 2017 Aug; 259():53-61. PubMed ID: 28108325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a fluorescence-based in vivo phagocytosis assay to measure mononuclear phagocyte system function in the rat.
    Tartaro K; VanVolkenburg M; Wilkie D; Coskran TM; Kreeger JM; Kawabata TT; Casinghino S
    J Immunotoxicol; 2015; 12(3):239-46. PubMed ID: 25027674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human mononuclear phagocyte system reunited.
    Haniffa M; Bigley V; Collin M
    Semin Cell Dev Biol; 2015 May; 41():59-69. PubMed ID: 25986054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sturcture and function of the mononuclear phagocytic system (MPS) in chronic rhinosinusitis. A light and electron microscopic investigation (author's transl)].
    Albegger KW
    Arch Otorhinolaryngol; 1976 Aug; 214(1):27-48. PubMed ID: 989310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter: Albumin microspheres as vehicles for achieving specificity in drug delivery.
    Kramer PA
    J Pharm Sci; 1974 Oct; 63(10):1646-7. PubMed ID: 4436811
    [No Abstract]   [Full Text] [Related]  

  • 6. Overcoming the Reticuloendothelial System Barrier to Drug Delivery with a "Don't-Eat-Us" Strategy.
    Tang Y; Wang X; Li J; Nie Y; Liao G; Yu Y; Li C
    ACS Nano; 2019 Nov; 13(11):13015-13026. PubMed ID: 31689086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow Cytometric Analysis of Mononuclear Phagocytes in Nondiseased Human Lung and Lung-Draining Lymph Nodes.
    Desch AN; Gibbings SL; Goyal R; Kolde R; Bednarek J; Bruno T; Slansky JE; Jacobelli J; Mason R; Ito Y; Messier E; Randolph GJ; Prabagar M; Atif SM; Segura E; Xavier RJ; Bratton DL; Janssen WJ; Henson PM; Jakubzick CV
    Am J Respir Crit Care Med; 2016 Mar; 193(6):614-26. PubMed ID: 26551758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of erythrocytes for delivery of chemotherapeutic agents to the reticuloendothelial system.
    Lynch WE; Sartiano GP; Rosenblum SL; Calkins JH; Ramsey CB
    Bibl Haematol; 1985; (51):42-9. PubMed ID: 2408600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mononuclear phagocytes of the intestine, the skin, and the lung.
    Scott CL; Henri S; Guilliams M
    Immunol Rev; 2014 Nov; 262(1):9-24. PubMed ID: 25319324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Illuminating the covert mission of mononuclear phagocytes in their regional niches.
    Chong SZ; Evrard M; Goh CC; Ng LG
    Curr Opin Immunol; 2018 Feb; 50():94-101. PubMed ID: 29275187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mononuclear phagocyte system: a new classification of macrophages, monocytes, and their precursor cells.
    van Furth R; Cohn ZA; Hirsch JG; Humphrey JH; Spector WG; Langevoort HL
    Bull World Health Organ; 1972; 46(6):845-52. PubMed ID: 4538544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization, a species-specific 'Marker of Self' CD47, and target physical properties.
    Sosale NG; Spinler KR; Alvey C; Discher DE
    Curr Opin Immunol; 2015 Aug; 35():107-12. PubMed ID: 26172292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shielding Therapeutic Drug Carriers from the Mononuclear Phagocyte System: A Review.
    Sathyamoorthy N; Dhanaraju MD
    Crit Rev Ther Drug Carrier Syst; 2016; 33(6):489-567. PubMed ID: 27992308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mononuclear phagocyte system revisited.
    Hume DA; Ross IL; Himes SR; Sasmono RT; Wells CA; Ravasi T
    J Leukoc Biol; 2002 Oct; 72(4):621-7. PubMed ID: 12377929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
    van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
    Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The RES and the mononuclear phagocyte system.
    Carr I
    Adv Exp Med Biol; 1976; 73 PT-A():3-9. PubMed ID: 998413
    [No Abstract]   [Full Text] [Related]  

  • 17. The Mononuclear Phagocyte System: The Relationship between Monocytes and Macrophages.
    Hume DA; Irvine KM; Pridans C
    Trends Immunol; 2019 Feb; 40(2):98-112. PubMed ID: 30579704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantifying rat pulmonary intravascular mononuclear phagocytes.
    Niehaus GD; Mehendale SR
    Anat Rec; 1998 Dec; 252(4):626-36. PubMed ID: 9845213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles and the mononuclear phagocyte system: pharmacokinetics and applications for inflammatory diseases.
    Song G; Petschauer JS; Madden AJ; Zamboni WC
    Curr Rheumatol Rev; 2014; 10(1):22-34. PubMed ID: 25229496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery.
    Zelepukin IV; Shevchenko KG; Deyev SM
    Nat Commun; 2024 May; 15(1):4366. PubMed ID: 38777821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.